NASDAQ:APDN Applied DNA Sciences (APDN) Stock Price, News & Analysis $1.32 -0.05 (-3.65%) (As of 09/18/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Applied DNA Sciences alerts: Email Address About Applied DNA Sciences Stock (NASDAQ:APDN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Applied DNA Sciences alerts:Sign Up Key Stats Today's Range$1.32▼$1.4250-Day Range$0.35▼$2.5452-Week Range$0.31▼$27.60Volume1.06 million shsAverage Volume3.73 million shsMarket Capitalization$1.30 millionP/E RatioN/ADividend YieldN/APrice Target$1.50Consensus RatingBuy Company OverviewApplied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.Read More… War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Applied DNA Sciences Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 33rd PercentileApplied DNA Sciences scored higher than 33% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingBuy Consensus RatingApplied DNA Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageApplied DNA Sciences has received no research coverage in the past 90 days.Read more about Applied DNA Sciences' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Applied DNA Sciences are expected to grow in the coming year, from ($1.80) to ($0.87) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Applied DNA Sciences is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Applied DNA Sciences is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApplied DNA Sciences has a P/B Ratio of 0.19. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Applied DNA Sciences' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted217.26% of the outstanding shares of Applied DNA Sciences have been sold short.Short Interest Ratio / Days to CoverApplied DNA Sciences has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Applied DNA Sciences has recently increased by 23.70%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldApplied DNA Sciences does not currently pay a dividend.Dividend GrowthApplied DNA Sciences does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted217.26% of the outstanding shares of Applied DNA Sciences have been sold short.Short Interest Ratio / Days to CoverApplied DNA Sciences has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Applied DNA Sciences has recently increased by 23.70%, indicating that investor sentiment is decreasing significantly. News and Social Media2.8 / 5News Sentiment0.06 News SentimentApplied DNA Sciences has a news sentiment score of 0.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.74 average news sentiment score of Industrial Products companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Applied DNA Sciences this week, compared to 1 article on an average week.Search Interest46 people have searched for APDN on MarketBeat in the last 30 days. This is an increase of 820% compared to the previous 30 days.MarketBeat Follows3 people have added Applied DNA Sciences to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.00% of the stock of Applied DNA Sciences is held by insiders.Percentage Held by InstitutionsOnly 22.22% of the stock of Applied DNA Sciences is held by institutions.Read more about Applied DNA Sciences' insider trading history. Receive APDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address APDN Stock News HeadlinesApplied DNA Sciences: Applied DNA Regains Compliance with Nasdaq Minimum Bid Price RequirementSeptember 18 at 8:33 PM | finanznachrichten.deApplied DNA Sciences (NASDAQ:APDN) Upgraded to Sell by StockNews.comSeptember 18 at 4:11 AM | americanbankingnews.comWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.September 18, 2024 | Porter & Company (Ad)Applied DNA Sciences: Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic ApplicationSeptember 17 at 12:12 PM | finanznachrichten.deApplied DNA Sciences, Inc. (NASDAQ:APDN) Sees Significant Growth in Short InterestSeptember 17 at 5:39 AM | americanbankingnews.comApplied DNA Sciences, Inc.: Applied DNA Launches Mpox Clade I and Clade II Testing ServiceSeptember 11, 2024 | finanznachrichten.deWhy Applied DNA Sciences (APDN) Stock Is SkyrocketingSeptember 11, 2024 | benzinga.comApplied DNA Sciences (NASDAQ:APDN) & UL Solutions (NYSE:ULS) Critical SurveySeptember 10, 2024 | americanbankingnews.comSee More Headlines APDN Stock Analysis - Frequently Asked Questions How have APDN shares performed this year? Applied DNA Sciences' stock was trading at $12.3360 on January 1st, 2024. Since then, APDN shares have decreased by 89.3% and is now trading at $1.32. View the best growth stocks for 2024 here. How were Applied DNA Sciences' earnings last quarter? Applied DNA Sciences, Inc. (NASDAQ:APDN) issued its quarterly earnings results on Thursday, August, 8th. The technology company reported $0.47 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.64) by $1.11. The technology company earned $0.80 million during the quarter, compared to the consensus estimate of $0.95 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 138.41% and a negative net margin of 214.42%. When did Applied DNA Sciences' stock split? Applied DNA Sciences's stock reverse split on the morning of Thursday, April 25th 2024. The 1-20 reverse split was announced on Thursday, April 25th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, April 25th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Applied DNA Sciences' major shareholders? Applied DNA Sciences' top institutional investors include Concourse Financial Group Securities Inc.. View institutional ownership trends. How do I buy shares of Applied DNA Sciences? Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Applied DNA Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV) and Gilead Sciences (GILD). Company Calendar Last Earnings8/08/2024Today9/18/2024Fiscal Year End9/30/2024Next Earnings (Estimated)12/05/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrial Products Industry Testing laboratories Sub-IndustryBusiness Services Current SymbolNASDAQ:APDN CUSIPN/A CIK744452 Webwww.adnas.com Phone(631) 240-8800Fax631-240-8900Employees70Year FoundedN/APrice Target and Rating Average Stock Price Target$1.50 High Stock Price Target$1.50 Low Stock Price Target$1.50 Potential Upside/Downside+11.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($17.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,950,000.00 Net Margins-214.42% Pretax Margin-217.42% Return on Equity-138.41% Return on Assets-58.97% Debt Debt-to-Equity RatioN/A Current Ratio3.91 Quick Ratio3.76 Sales & Book Value Annual Sales$3.40 million Price / Sales0.39 Cash FlowN/A Price / Cash FlowN/A Book Value$7.13 per share Price / Book0.19Miscellaneous Outstanding Shares985,000Free Float975,000Market Cap$1.33 million OptionableOptionable Beta0.37 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:APDN) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredCrypto ‘Banana Zone’ Incoming…What if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied DNA Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied DNA Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.